Our Story

Spectrum Medical Diagnostics is an industry pioneer whose mission and passion is to support the healthcare community.

With over twenty five years in the industry, we have experience customizing and tailoring products to our clients needs, customer service is integral to our organization.

What makes our organization unique is our knowledge of the industry, Health Canada compliance, and mission to give back to the community to further drive positive change.

Why Spectrum Medical Diagnostics?

We are constantly evolving by acquiring new, leading edge technologies.

Our Experience

Spectrum Medical Diagnostics Inc. is a leading supplier of drug test kits, alcohol testing kits and several other rapid diagnostic screening devices in Canada.

With nearly 40 years of combined experience, Spectrum Medical Diagnostics has demonstrated a commitment to servicing medical diagnostic and drug and alcohol screening providers.

Service & Value

We operate with strict compliance according to Health Canada regulations and we align our reputation and resources with ISO Certified companies.

Our acquisition model prioritizes North American-made products and Canadian manufacturers when it comes to the alcohol testing & drug test kits and other screening devices we supply.

Our Mission

" At Spectrum Medical Diagnostics Inc., we aim to exceed your expectations. From the application of screening diagnosis to interpreting test results, you can count on us to facilitate industry protocol and best practices. Guaranteed. "

- Sharmin, Sriram, CEO and Founder of Spectrum MDX

Meet Our Team

Our Founder & Chief Executive Officer


Sharmin Sriram

After working as a POCT product specialist supporting Medical Directors and toxicology experts for over 25 years, Sharmin transformed her passion for personalizing healthcare services into her next successful business venture and formed Spectrum Medical Diagnostics in 2008.

She has been at the forefront of rapid diagnostic technology for more than 25 years and has a proven track record of introducing innovative products and solutions that accelerate POCT clinical diagnosis.

In 1999, Sharmin recognized the need for a more sensitive  and specific chemistry for rapid EDDP (Methadone metabolite) detection and was first to launch a rapid POCT device for this metabolite into the Canadian marketplace.

Sharmin has positioned her performance as a leader and aligns her business intelligence with North-American products that exceed her expectations of quality.

Her entrepreneurial spirit has enabled her to build long-lasting relationships with manufacturers and industry peers that broaden her company’s product portfolio.